 |
SYDNEY, Aug. 20, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kazia's paxalisib (formerly GDC-0084) for the treatment of glioblastoma,...
The importance of a vibrant, flexible, and inspiring workspace cannot be overstated in a world where the boundaries of work and personal life cont...
Given the abundance of unknowns, predicting how and when the market will move has become a mug’s game. Anyone else tired of speculating about w...
Imagine being able to swap your investment property for another real estate while deferring the capital gains taxes. Of course, the 1031 tax-defer...
The fourth and final season of HBO’s hit series, Succession, is drawing to a close. Captivating audiences with its gripping drama and pithy one-li...
Making the most of your home without having to move is actually a lot easier than you think. You don’t have to leave your family home just because y...
A limo service business can be very rewarding financial-wise. Your job duties include scheduling your vehicles to pick up and drive clients to vario...